TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

Biotech company 10x Genomics (NASDAQ:TXG) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.6% year on ...

10x Genomics Q1 Earnings Call Highlights

Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument pl ...

Bionano Genomics: Bionano Announces Leadership Transition

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president ...

10x Genomics, Inc.: 10x Genomics Reports First Quarter 2026 Financial Results

PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for ...

10x Genomics Reports First Quarter 2026 Financial Results

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first ...

Bionano Announces Leadership Transition

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief executive officer, effective May ...